Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
7.24
-0.08 (-1.09%)
At close: Jul 19, 2024, 4:00 PM
7.31
+0.07 (0.97%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Amneal Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2014
Revenue
2,4952,3942,2122,0941,9931,626
Upgrade
Revenue Growth (YoY)
9.82%8.20%5.67%5.08%22.51%-2.20%
Upgrade
Cost of Revenue
1,6151,5731,4281,3251,3641,273
Upgrade
Gross Profit
880.44820.57784.71768.97628.39353
Upgrade
Selling, General & Admin
440.17429.68399.7365.5326.73289.6
Upgrade
Research & Development
164.56163.95195.69201.85179.93188.05
Upgrade
Other Operating Expenses
133.3837.06283.5248.7130.58124.03
Upgrade
Operating Expenses
738.11630.69878.91616.06537.24601.68
Upgrade
Operating Income
142.33189.88-94.2152.9291.16-248.68
Upgrade
Interest Expense / Income
227.02210.63158.38136.33146168.21
Upgrade
Other Expense / Income
70.0654.79-129.25-5.23-41.54-438.3
Upgrade
Pretax Income
-154.75-75.54-123.3221.82-13.321.41
Upgrade
Income Tax
13.948.456.6611.2-104.36383.33
Upgrade
Net Income
-168.69-83.99-129.9910.6291.06-361.92
Upgrade
Net Income Growth
----88.33%--
Upgrade
Shares Outstanding (Basic)
307176151149147132
Upgrade
Shares Outstanding (Diluted)
307176151152149132
Upgrade
Shares Change
102.01%16.69%-0.58%1.95%12.72%3.81%
Upgrade
EPS (Basic)
-0.74-0.48-0.860.070.62-2.74
Upgrade
EPS (Diluted)
-0.73-0.48-0.860.070.61-2.74
Upgrade
EPS Growth
----88.52%--
Upgrade
Free Cash Flow
155.99298.7816.31190.88317.17-45.48
Upgrade
Free Cash Flow Per Share
0.511.700.111.282.15-0.34
Upgrade
Gross Margin
35.28%34.28%35.47%36.73%31.54%21.70%
Upgrade
Operating Margin
5.70%7.93%-4.26%7.30%4.57%-15.29%
Upgrade
Profit Margin
-6.76%-3.51%-5.88%0.51%4.57%-22.25%
Upgrade
Free Cash Flow Margin
6.25%12.48%0.74%9.12%15.92%-2.80%
Upgrade
Effective Tax Rate
---51.31%-1790.10%
Upgrade
EBITDA
299.04364.49275.23391.55368.09396.85
Upgrade
EBITDA Margin
11.98%15.23%12.44%18.70%18.47%24.40%
Upgrade
Depreciation & Amortization
226.78229.4240.18233.41235.39207.24
Upgrade
EBIT
72.26135.0935.05158.15132.7189.62
Upgrade
EBIT Margin
2.90%5.64%1.58%7.55%6.66%11.66%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).